StockData
QHSLab, Inc. logo

QHSLab, Inc. (USAQ) stock

USAQOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.32+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.38MP/E –Yield –

QHSLab, Inc. grew revenue 24.6% to $3.02M over the twelve months to Jun 30, 2026. Operating income fell 48.9% to $82.62K, moving the operating margin from 6.7% to 2.7%. At the latest close the market valued the company at $7.38M.

Revenue
$3.02M
+24.6% vs. a year earlier
Operating income
$82.62K
-48.9% vs. a year earlier
EPS, diluted
-$0.03
TTM Q2 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$7.38M
P/E ratio
–
Price to sales
2.45
Price to book
4.74
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$3.02M
Net income
-$390.73K
EPS, diluted
-$0.03
Book value per share
$0.07
Diluted shares
23M

Trading

Previous close
$0.32
Open
$0.32
Day's range
$0.32 – $0.32
Volume
0
Average volume (20 days)
4,244

Market cap history

Month-end market cap since 2014, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodUSAQS&P 500DifferenceUSAQ per yearS&P 500 per year
1 month-8.6%+0.6%−9.2 pts
3 months+0.9%+3.4%−2.4 pts
Year to date-47.2%+13.3%−60.5 pts
1 year+46.8%+16.6%+30.2 pts
3 years+966.7%+86.4%+880.3 pts+120.1%+23.1%
5 years-55.6%+81.9%−137.4 pts-15.0%+12.7%
10 years+190.9%+318.9%−127.9 pts+11.3%+15.4%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$3.02M+24.6% YoY

Gross profit

$2.04M+27.2% YoY

Operating income

$82.62K-48.9% YoY

Net income

-$390.73K

EPS, diluted

-$0.03
Reported periodTrailing twelve months

Press releases

Releases QHSLab filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About QHSLab

Surgical & Medical Instruments & Apparatus

QHSLab, Inc. is a digital health company that enables independent, physician-led primary care practices to detect, document, and manage behavioral health conditions. Its workflow-integrated digital platform facilitates population-based screening, adaptive clinical risk assessments, automated documentation within electronic health records, and longitudinal non-face-to-face care management. Alongside its digital software, the company offers AllergiEnd, an allergy diagnostics and treatment line featuring disposable skin test applicators and customized immunotherapy support to evaluate and treat allergic conditions directly within clinical practices. Its primary target clientele consists of independent medical practices with one to ten healthcare providers.

Company profile, executives and history

QHSLab stock: common questions

What is QHSLab's stock price?

USAQ closed at $0.32 on Oct 19, 2026, up 0.00% on the day.

What is QHSLab's market cap?

QHSLab was worth $7.38M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is USAQ's P/E ratio?

QHSLab lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.03), so it has no meaningful P/E ratio.

How much revenue does QHSLab make?

QHSLab reported revenue of $3.02M for the twelve months to Jun 30, 2026, up 24.6% from a year earlier.

Does QHSLab pay a dividend?

No. QHSLab has not paid a cash dividend over the last twelve months.

How has USAQ stock performed over the past year?

Including dividends, USAQ returned +46.8% over the past year, against +16.6% for the S&P 500.

Who are QHSLab's competitors?

Companies most similar to QHSLab by business, industry and size include LUCD, AURX, INBS, VYCO, SINT.

See a number that looks wrong?